Beckman Coulter Life Sciences has announced that it is Genedrive’s first US distributor as the world continues to seek solutions in response to the coronavirus pandemic.® 96SARS-CoV-2 kit. The contract with genedriveplc (LSE: GDR), a molecular diagnostics company close to patients, is intended to be distributed throughout the United States and Europe.
Genedrive® The 96 SARS-CoV-2 Kit is a simple one-step RT-PCR test for detecting SARS-CoV-2 RNA.It provides lyophilization reagent It enables the stability of the product and allows it to be transported and stored around. The ease of assay setup streamlines laboratory workflows, improves overall throughput, and reduces potential assay setup errors. Genedrive® The 96 SARS-CoV-2 kit has the CE-IVD mark and is currently undergoing FDA review for an Emergency Use Authorization (EUA).
There is still a significant need to continue the COVID-19 test, even when the vaccine is being administered. This collaboration provides a turnkey solution for professional laboratories looking to establish new or expanded test capacities with reduced consumables and labor costs. The ability to streamline workflows by simultaneously preparing sampling and downstream assay setups is an important step in advancing the COVID testing workflow, increasing throughput and reducing consumables usage. “
Beckman Coulter, President of Life Sciences, Greg Milosevic
For more information Genedrive® 96SARS-CoV-2 kit Please see the product overview page.
Beckman Coulter Life Sciences was founded as the first US distributor of the genedrive plc COVID-19 kit.
Source link Beckman Coulter Life Sciences was founded as the first US distributor of the genedrive plc COVID-19 kit.